气相色谱-质谱法分析乳腺癌大鼠尿液中的代谢物

基于气相色谱-质谱法,建立了乳腺癌大鼠尿液中代谢物的分析方法。构建了乳腺癌大鼠模型。分别收集乳腺癌组、未成瘤组和健康对照组大鼠尿液样本,经脲酶处理后,用甲醇∶乙腈=2∶1(V/V)进行提取,硅烷化试剂N,O-双甲氧基三氟乙酰胺+1%三甲基氯硅烷(BSTFA+1%TMCS)衍生,然后采用气相色谱-质谱法分析尿液样本的代谢谱,并用随机森林(RF)算法对实验结果进行分析。结果表明,三组实验数据被成功分类,并发现甲基丙二酸、3-羟基丁酸、苏糖酸、对羟基苯乙酸、D-麦芽糖等组分在乳腺癌组和健康对照组中具有显著差异。     

腌制食品中N-亚硝胺类化合物分析方法的研究进展北大核心CSCD

本文简要介绍了腌制食品中N-亚硝胺类化合物的种类及特性,重点综述了气相色谱法、气相色谱-质谱法、液相色谱法、液相色谱-质谱法和胶束电动毛细管色谱法等技术在腌制食品中N-亚硝胺类化合物分析中的应用进展(引用文献39篇)。     

腌制食品中N-亚硝胺类化合物分析方法的研究进展

本文简要介绍了腌制食品中N-亚硝胺类化合物的种类及特性,重点综述了气相色谱法、气相色谱-质谱法、液相色谱法、液相色谱-质谱法和胶束电动毛细管色谱法等技术在腌制食品中N-亚硝胺类化合物分析中的应用进展(引用文献39篇)。     

气相色谱-负离子化学源/质谱法(GC-NCI/MS)分析鱼类和贝类样品中多溴联苯醚和多溴联苯

将气相色谱-负离子化学源/质谱法(GC-NCI/MS)应用于分析鱼类和贝类样品中5种多溴联苯醚(PBDEs)和5种多溴联苯(PBBs)残留.鱼类和贝类样品以正己烷/丙酮(1∶1,V/V)作为提取剂,采用超声萃取法,提取液经酸性硅胶和中性硅胶层析柱净化和正己烷洗脱后,以PCB-103为内标物和GC-NCI-MS的选择离子...     

气相色谱-电子轰击源质谱法测定茶叶中氟虫腈残留量

建立了茶叶中氟虫腈残留量快速测定的气相色谱-电子轰击源质谱法。茶叶中的氟虫腈用正己烷-丙酮(7:3,V/V)混合液提取,经石墨化碳黑固相萃取小柱净化后,用正己烷-丙酮(9:1,V/V)混合液洗脱,浓缩定容后,用气相色谱-电子轰击源质谱法测定,外标法定量。结果表明,目标物质在0.001~0.040 mg/L范围内的线性关系良好;空白样品在0.002~0.010 mg/L范围三水平加标回收实验的平均回收率在96.6%~114.2%之间,相对标准偏差(n=6)为2.9%~4.4%;方法的定量限为0.001 mg/kg。该方法能满足茶叶中氟虫腈残留量0.002 mg/kg的检测要求。     

土壤中多种有机磷及氨基甲酸酯类农药残留量的气相色谱-质谱法测定

建立了气相色谱-质谱法测定土壤中12种有机磷和氨基甲酸酯类农药残留分析方法。以丙酮-石油醚(4∶1,V/V)为提取剂,采用超声波提取土壤中农药残留,经弗罗里土层析柱净化,气相色谱-质谱(选择离子模式)法同时测定了土壤中多种有机磷和氨基甲酸酯类农药。该法对0.1μg/mL和0.5μg/mL两个浓度添加水平的回收率分别为70.1%~119.0%和78.1%~119.1%,相对标准偏差分别为6.30%~9.80%和5.20%~8.23%。     

超声萃取分离-气相色谱-质谱法测定土壤中的3种酰胺类化合物含量

采用超声萃取-气相色谱-质谱法测定土壤中N,N-二甲基甲酰胺、N,N-二甲基乙酰胺和N,N-二甲基丙烯酰胺等3种酰胺类化合物的含量。样品经丙酮超声提取,在气相色谱分离中用DB-624色谱柱为固定相,在质谱分析中采用全扫描和选择离子监测模式。3种酰胺类化合物的质量浓度均在0.05~20.0mg·L~(-1)范围内与其峰面积呈线性关系,方法的检出限(3S/N)在0.5~1.5mg·kg~(-1)之间。加标回收率在85.3%~110%之间,测定值的相对标准偏差(n=7)在1.5%~5.3%之间。     

超声萃取-气相色谱-质谱联用测定海洋沉积物中39种多溴联苯醚残留

建立了超声萃取-气相色谱-质谱法测定海洋沉积物中39种多溴联苯醚残留的分析方法.样品用V(正己烷):V(二氯甲烷) =1:1混合溶液提取,超声(控制水浴温度为25 ℃)提取60 min,采用硅胶和氧化铝净化,负化学离子源-气相色谱-质谱法进行检测,39种组分图谱在49 min 内能得到很好的分离. 39种混合样品的检出限为0.003～0.10 μg/kg; 加标回收率为66.2%～118.6%;相对标准偏差为0.8%～18.2%.用于实际样品分析,结果令人满意.     

中草药中有机磷及氨基甲酸酯类农药残留量的GC-MS测定

气相色谱-质谱法同时测定中草药中多种有机磷及氨基甲酸酯类农药残留量.采用V(乙腈)∶V(丙酮)＝3∶7混合溶剂微波辅助提取,弗罗里硅土和中性氧化铝层析柱净化,气相色谱-质谱(GC-MS)联用检测,农药混标在0.01～1.0 μg/mL范围内线性良好,在0.5、0.1、0.05 μg/mL 3个水平添加平均回收率分别为86.5%～110.6%、81.2%～108.3%和72.9%～122.3%,相对标准偏差分别为2.6%～8.3%、4.6%～9.7%和2.3%～10.7%.     

固相萃取-气相色谱法测定茶叶中多种有机磷农药

建立了固相萃取-气相色谱法同时测定茶叶中16种有机磷农药残留的方法.样品用丙酮超声提取后,经自制的N-丙基乙二胺(PSA)/活性炭固相萃取柱净化,以混合溶剂乙腈/甲苯(V(乙腈)∶V(甲苯)=1∶3)洗脱,采用气相色谱-氮磷检测器(GC-NPD)测定.方法的回收率在62.8%～109.1%之间,相对标准偏差小于14.7%1,6种有机磷农药的检出限在0.01～0.16 mg/kg之间.方法快速简便、经济实用。     

Identifying potential serum biomarkers of breast cancer through targeted free fatty acid profiles screening based on a GC–MS platform

Recent advances suggest that abnormal fatty acid metabolism highly correlates with breast cancer, which provide clues to discover potential biomarkers of breast cancer. This study aims to identify serum free fatty acid (FFA) metabolic profiles and screen potential biomarkers for breast cancer diagnosis. Gas chromatography–mass spectrometry and our in-house fatty acid methyl ester standard substances library were combined to accurately identify FFA profiles in serum samples of breast cancer patients and breast adenosis patients (as controls). Potential biomarkers were screened by applying statistical analysis. A total of 18 FFAs were accurately identified in serum sample. Two groups of patients were correctly discriminated by the orthogonal partial least squares–discriminant analysis model based on FFA profiles. Seven FFA levels were significantly higher in serum from breast cancer patients than that in controls, and exhibited positive correlation with malignant degrees of disease. Furthermore, five candidates (palmitic acid, oleic acid, cis-8,11,14-eicosatrienoic acid, docosanoic acid and the ratio of oleic acid to stearic acid) were selected as potential serum biomarkers for differential diagnosis of breast cancer. Our study will help to reveal the metabolic signature of FFAs in breast cancer patients, and provides valuable information for facilitating clinical noninvasive diagnosis.     

Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers

Breast cancer is the most common cancer in women worldwide. It is necessary to identify biomarkers for early detection, to make accurate prognoses, and to monitor for any recurrence of the cancer. In order to identify potential breast cancer biomarkers, we analyzed the plasma samples of women diagnosed with breast cancer and age-matched normal healthy women by mTRAQ-based stable isotope-labeling mass spectrometry. We identified and quantified 204 proteins including thrombospondin-1 (THBS1) and bromodomain and WD repeat-containing protein 3 (BRWD3) which were increased by more than 5-fold in breast cancer plasma. The plasma levels of the two proteins were evaluated by Western blot assay to confirm for their diagnostic value as serum markers. A 1.8-fold increase in BRWD3 was observed while comparing the plasma levels of breast cancer patients (n = 54) with age-matched normal healthy controls (n = 30), and the area under the receiver operating characteristic curve (AUC) was 0.917. THBS1 was detected in pooled breast cancer plasma at the ratio similar to mTRAQ ratio (> 5-fold). The AUC value for THBS1 was 0.875. The increase of THBS1 was more prominent in estrogen receptor negative and progesterone receptor negative patients than receptor-positive patients. Our results are evidence of the diagnostic value of THBS1 in detecting breast cancer. Based on our findings, we suggest a proteomic method for protein identification and quantification lead to effective biomarker discovery.     

Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry

A quantitative analysis of polyamines in urine and serum by liquid chromatography-tandem mass spectrometry (LC-MS/MS) is described. The polyamines were carbamylated with isobutyl chloroformate, extracted with diethyl ether under pH 9.0, and analyzed by LC-MS/MS with single reaction monitoring mode. The limit of quantification was 1 ng/mL based on a signal-to-noise ratio>3, and the correlation coefficient (r2) for the calibration curves was >0.99 for both urine and serum samples. The present method was applied to urine and serum samples from 30 breast cancer patients and 30 normal female controls. There was no significant difference in the urinary polyamine levels between breast cancer patients and controls. However, 1,3-diaminopropane, putrescine, spermine and N-acetylspermidine levels in serum increased in breast cancer patients. These four serum polyamines may be a good index to study both production and metabolism of polyamines, and a useful tool in assessment of the polyamine status of breast cancer patients.     

Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer

It is known that patients suffering from cancer diseases excrete increased amounts of modified nucleosides with their urine. Especially methylated nucleosides have been proposed to be potential tumor markers for early diagnosis of cancer. For determination of nucleosides in randomly collected urine samples, the nucleosides were extracted using affinity chromatography and then analyzed via reversed phase high-performance liquid chromatography (HPLC) with UV-detection. Eleven nucleosides were quantified in urine samples from 51 breast cancer patients and 65 healthy women.The measured concentrations were used to train a Support Vector Machine (SVM) and a k-nearest-neighbor classifier (k-NN) to discriminate between healthy control subjects and patients suffering from breast cancer. Evaluations of the learned models by computing the leave-one-out error and the prediction error on an independent test set of 29 subjects (15 healthy, 14 breast cancer patients) showed that by using the eleven nucleosides, the occurrence of breast cancer could be forecasted with 86% specificity and 94% sensitivity when using an SVM and 86% for both specificity and sensitivity with the k-NN model.     

液相色谱-质谱联用系统在肝硬化不同阶段代谢轮廓研究中的应用

采用高效液相色谱-轨道离子阱质谱联用(HPLC-LTQ Orbitrap XL MS)代谢组学研究平台分析不同阶段肝硬化病人和健康人群的血清标本,获取代谢轮廓。采用模式识别方法结合非参数检验对数据进行分析。研究发现,由肝硬化A级组、B级组、C级组和健康对照组的代谢轮廓构建的正交偏最小二乘判别分析(OPLS-DA)模型(R2（Y）=90.1%, Q2=66.7%),对检测组数据的预测准确率达到93.8%,具有很好的判别能力。从代谢轮廓中可以鉴别出用于区分不同疾病阶段的特异性代谢标志物,如溶血磷脂酰胆碱、甘氨鹅去氧胆酸、半胱氨酸、甘氨酸、氨基己二酸、哌可酸等。研究结果表明: 利用代谢组学方法获得的血清代谢轮廓可以用来构建区分模型和寻找代谢标志物,为乙肝肝硬化的诊断和监测提供支持和依据。     

Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer

Several studies have demonstrated that sera from patients with cancer contain antibodies that recognize a unique group of autologous antigens called tumor-associated antigens (TAA). In the current study, we employed an immunoproteomic approach, combining 2DE, Western blot, and MALDI-MS to identify TAA in the sera of patients diagnosed with infiltrating ductal or in situ carcinoma breast cancer. Sera obtained from 25 newly diagnosed patients with stage II breast cancer and 20 healthy volunteers was evaluated for the presence of novel TAA. Alpha 1-antitrypsin (A1AT) antibodies were detected in 24 of 25 patients with breast cancer (96%) and in 2 of 20 controls (10%). Sensitivity of detection of autoantibodies against A1AT in patients with breast cancer was 96%. Our preliminary results suggest that A1AT and autoantibodies against alpha 1 antitrypsin may be useful serum biomarkers for early-stage breast cancer screening and diagnosis.     

血清六种微量元素与胃癌的相关性

为研究胃癌患者血清微量元素与胃癌的相关性 ,探讨其在胃癌诊断中的应用 ,取甘肃省武威市 2 0例胃癌患者血清作为胃癌组 (C组 ) ,3 0例当地健康志愿者血清作为对照组 (N组 ) ,用电感耦合等离子体原子发射光谱仪 (ICP -AES)进行了 6种微量元素的测定 ,并将结果用SPSS软件作统计分析。结果表明 ,胃癌组血清微量元素值高于对照组的元素有Cu、Cu/Zn、Fe (P <0 0 1 ) :低于对照组的元素有Zn、Mn (P <0 0 5 )。经Logistic回归分析 ,进入方程的为Zn元素 (P<0 0 5 )。多种微量元素联合诊断胃癌的准确率为 87% ,误诊率为 8%。提示 ,甘肃省武威市胃癌患者血清中Cu、Cu/Zn、Fe的升高以及Zn、Mn的降低与胃癌的发生具有相关性。其中Zn与胃癌的发生关系最为密切 ,且Zn降低可能为胃癌发生的癌前因素。测定血清微量元素值可以作为早期诊断胃癌的一种工具。     

乳腺癌患者化疗前后血清Ca、P、Mg、Zn含量与疗效的关系

目的探讨乳腺癌患者化疗效果对血清中钙(Ca)、磷(P)、镁(Mg)以及锌(Zn)含量的影响。方法选取普宁市人民医院进行化疗的乳腺癌患者80例作为化疗组,观察患者化疗前后血清中Ca、P、Mg以及Zn的水平变化,另选80例健康女性作为健康人组,检测其血清Ca、P、Mg、Zn水平,并进行对比分析。结果化疗组Ca、Mg含量明显低于健康人组(P0.05),Zn含量明显高于健康人组(P0.05),P含量与健康人组相比无统计学意义(P0.05);化疗后Ca、Mg含量显著高于化疗前(P0.05),Zn含量显著低于化疗前(P0.05),P含量略低于化疗前(P0.05)。结论血清Ca、P、Mg、Zn含量随着临床治疗效果所变化,可作为检测化疗效果的有效反应因子,在疗效判定方面具有一定的参考价值。     

Liquid chromatographic and mass spectrometric analysis of human serum acid alpha-1-glycoprotein

Human serum acid alpha-1-glycoprotein (AGP, orosomucoid) content of healthy individuals and cancer patients was measured, isolated and purified using a protocol of fast and biocompatible sample preparation, ion exchange and dye-ligand affinity chromatographic methods. In comparison to the healthy individuals significantly higher serum AGP levels were found in a wide spectrum of cancer patients, indicating its diagnostic value in the malignant disease. Oligosaccharide content of AGP samples was separated following PNGase F enzyme digestion and analysed by RP-HPLC and MALDI-TOF mass spectrometry. RP-HPLC and MALDI-TOF mass spectrometric analysis of sugar constituents of AGP specimen originated from selected cancer patients with high serum AGP levels indicated the appearance of anomal distribution of bi-, tri- and tetra-antennary oligosaccharide structures compared to the healthy controls.     

Elevated levels of hydroxylated phosphocholine lipids in the blood serum of breast cancer patients

The difference in serum phospholipid content between stage‐IV breast cancer patients and disease‐free individuals was studied by employing a combination of chemometric statistical analysis tools and mass spectrometry. Chloroform‐extracted serum samples were profiled for their lipid class composition and structure using precursor ion, neutral loss, and product ion tandem mass spectrometric (MS/MS) scanning experiments. Changes in the relative abundance of phospholipids in serum as a consequence of cancer progression, measured through electrospray ionization (ESI) mass spectrometry of flow‐injected serum samples collected from 25 disease‐free individuals and 50 patients diagnosed with stage‐IV breast cancer, were statistically evaluated using principal component analysis (PCA), analysis of variance (ANOVA) and receiver operating characteristic (ROC) analysis. Lipids whose abundance changed significantly as a consequence of cancer progression were structurally characterized using product ion spectra, and independently quantified using precursor ion scan experiments against an internal standard of known concentration. Phosphocholine lipids that displayed a statistically significant change as a consequence of cancer progression were found to contain an oxidized fatty acid moiety as determined by MS³ experiments. Copyright © 2009 John Wiley & Sons, Ltd.